Intra-ophthalmic Artery Chemotherapy for Retinoblastoma

Matthew W. Wilson, Brian Tse, Rachel C. Brennan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today.

Original languageEnglish (US)
Title of host publicationClinical Ophthalmic Oncology: Retinoblastoma, Second Edition
PublisherSpringer Berlin Heidelberg
Pages129-136
Number of pages8
ISBN (Print)9783662434512, 9783662434505
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Wilson, M. W., Tse, B., & Brennan, R. C. (2015). Intra-ophthalmic Artery Chemotherapy for Retinoblastoma. In Clinical Ophthalmic Oncology: Retinoblastoma, Second Edition (pp. 129-136). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-43451-2_12